European Medicines Agency Restructures To Tackle New Challenges
Multiple Pressures Prompt ‘Future Proofing’ Exercise
A restructuring involving the setting up of four new task forces is aimed at improving how the European Medicines Agency responds to issues such as permanent staff reductions and challenges in regulatory science, digital business transformation, and clinical trial strategy.
